Schlagwort: Investment
Rolle rückwärts!
Zunehmend mehr Unternehmen verlassen die Börse – ein Gegensteuern ist dringend erforderlich.
Die Zahl der Börsenabgänge hat jene der IPOs und Listings in den letzten...
Heading the digital transformation in the life sciences industry
Headquartered in Ghent, Belgium, BioLizard is a go-to partner for data strategy and execution with companies ranging from drug discovery to clinical research and...
How to achieve investment readiness in the food industry?
When and in what form do you get investors on board? This is the key question for every founding team and every start-up. In...
Doing good needs solid financing
What starts with a good sustainable idea is not automatically a sustainable business model. The road to a functioning social business is long and...
Reimagining meat
Plant-based and cultivated meat are essential for meeting our climate targets because they can deliver the meat people want with up to 92% less...
The number of circular economy start-ups in Germany is growing
In the last years, the number of circular economy start-ups in Germany has increased significantly. There are too many different very heterogenous definitions to...
Out now: Circular Bioeconomy 2023
Advancing the circular bioeconomy!
The global circular bioeconomy is picking up speed, despite – or perhaps precisely because of – today’s escalating ecological crises, energy...
A trimmed biotech basket
Following a strong performance in the summer period, shares of German biotech companies were affected by another global downward trend. We have adjusted the...
Bewältigung der Adipositas-Pandemie gewinnt an Dynamik
Bei der Behandlung von Fettleibigkeit entsteht eine Wertschöpfungskette, die weit über die Gesundheitsindustrie hinausreicht. Der Bedarf an Lösungen ist angesichts des Ausmaßes enorm. Rückenwind...
Helix BioPharma: Mit basischem Milieu gegen Krebszellen
Aktienportrait des kanadischen Biotech-Unternehmens, das Wirkstoffe im Bereich der Tumorbekämpfung entwickelt.
Helix BioPharma Corp. (HBP) ist ein biopharmazeutisches Unternehmen im klinischen Stadium, das auf der...